Stage-specific associations between beta blocker use and prognosis after colorectal cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stage-specific associations between beta blocker use and prognosis after colorectal cancer
Authors
Keywords
-
Journal
CANCER
Volume 120, Issue 8, Pages 1178-1186
Publisher
Wiley
Online
2014-01-11
DOI
10.1002/cncr.28546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Imputation UsingSASSoftware
- (2015) Yang Yuan Journal of Statistical Software
- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Protection From Colorectal Cancer After Colonoscopy
- (2013) Hermann Brenner et al. ANNALS OF INTERNAL MEDICINE
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
- (2013) H. M. Wang et al. ANNALS OF ONCOLOGY
- Beta blocker use and colorectal cancer risk
- (2012) Lina Jansen et al. CANCER
- Impact of beta blockers on epithelial ovarian cancer survival
- (2012) Elena S. Diaz et al. GYNECOLOGIC ONCOLOGY
- Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
- (2012) Helene Hartvedt Grytli et al. PROSTATE
- Stimulation of Host Bone Marrow Stromal Cells by Sympathetic Nerves Promotes Breast Cancer Bone Metastasis in Mice
- (2012) J. Preston Campbell et al. PLOS BIOLOGY
- Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
- (2012) P J Fitzgerald Clinical Epidemiology
- Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma
- (2011) Vincenzo De Giorgi et al. ARCHIVES OF INTERNAL MEDICINE
- Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants and associations with quality of life
- (2011) L Jansen et al. BRITISH JOURNAL OF CANCER
- Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
- (2011) Sunil M. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
- (2011) S. Lemeshow et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.
- (2011) Steven W. Cole et al. CLINICAL CANCER RESEARCH
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- Age-Specific Administration of Chemotherapy and Long-Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population-Based Prospective Cohort
- (2011) L. Jansen et al. ONCOLOGIST
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
- (2010) E. K. Sloan et al. CANCER RESEARCH
- Is norepinephrine an etiological factor in some types of cancer?
- (2008) Paul J. Fitzgerald INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started